Cardiff Oncology logo
Cardiff Oncology CRDF
$ 1.53 2.0%

Quarterly report 2026-Q1
added 05-14-2026

report update icon

Cardiff Oncology DSO Ratio 2011-2026 | CRDF

Annual DSO Ratio Cardiff Oncology

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
294 284 396 617 435 320 304 162 55.7 96.2 115 73.9 111 136 140 - - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
617 55.7 236

Quarterly DSO Ratio Cardiff Oncology

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
495 297 351 493 - 296 236 152 - 116 354 795 - 319 224 605 - 373 353 450 - 1.82 K 1.82 K 663 - 346 266 262 - 178 423 513 38 341 69 85.2 135 103 88.7 75.4 114 157 183 55.9 92.4 90.4 93 55.8 153 165 147 94.8 94.3 72.7 370 357 - 164 113 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.82 K 38 308

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
2.94 K - 5743.5 % $ 69.7 M canadaCanada
Compugen Ltd. Compugen Ltd.
CGEN
400 $ 2.02 -0.98 % $ 189 M israelIsrael
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
29 - 1.35 % $ 17.8 M chinaChina
Coherus BioSciences Coherus BioSciences
CHRS
559 $ 1.42 - $ 166 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
60.8 - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
1.73 - - $ 2.17 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
31.4 - -34.95 % $ 21.5 M germanyGermany
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 51.48 -0.23 % $ 4.63 B schweizSchweiz
Celyad Oncology SA Celyad Oncology SA
CYAD
64.4 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
103 - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
321 $ 29.6 3.64 % $ 1.97 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
IMV IMV
IMV
2.16 K - - $ 13.1 M canadaCanada
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
3.66 K - -4.36 % $ 27 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
76.5 $ 14.57 -0.21 % $ 209 M usaUSA
Advaxis Advaxis
ADXS
3.28 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 2.91 -5.52 % $ 4.79 M israelIsrael
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 22.79 5.8 % $ 2.9 B usaUSA